Form 4: Teladoc Health Executive Stephany Verstraete Sells 15,000 Shares

Stephany Verstraete, Chief Marketing Officer of Teladoc Health, sold 15,000 shares of common stock on August 7, 2024, at a price of $7.6 per share.

Summary

• On August 7, 2024, Stephany Verstraete, the Chief Marketing Officer of Teladoc Health, Inc. (TDOC), sold 15,000 shares of the company's common stock.
• The sale was executed at a price of $7.6 per share.
• Following the transaction, Verstraete directly owns 45,158 shares of Teladoc Health.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on April 30, 2024.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale under a pre-arranged trading plan, so it doesn't convey strong positive or negative sentiment.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although this sale was conducted under a pre-arranged trading plan.

Future Outlook

The document does not contain any forward-looking statements regarding the company's future performance.

Industry Context

Insider transactions are routinely monitored by investors to gauge executive sentiment and potential future performance, although sales under 10b5-1 plans are less indicative of immediate sentiment.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment.

Key Dates